Znn3bq.jpeg
²é¿´: 1096  |  »Ø¸´: 15
¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û11´Î£¬×÷Õßluai071Ôö¼Ó½ð±Ò 8.5 ¸ö
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

luai071

ľ³æ (ÖøÃûдÊÖ)


[×ÊÔ´] ÍÆ¼öWileyµç×ÓÊéÒ»±¾

G Protein-Coupled Receptors as Drug Targets: Analysis of Activation and Constitutive Activity
Publisher:  Wiley-VCH
Number Of Pages:  304
Publication Date:  2006-01-09
Sales Rank:  488335
ISBN / ASIN:  3527308199
EAN:  9783527308194
Binding:  Hardcover
Manufacturer:  Wiley-VCH
Studio:  Wiley-VCH


Book Description:

With its particular emphasis on the constitutive activity of G-protein-coupled receptors (GPCRs)s, this book comprehensively discusses an important biological process that has not yet been covered in such depth in any other existing books on GPCRs. The international team of highly distinguished authors addresses in detail current models and concepts, to introduce medicinal chemists, physiologists, pharmacologists, and medical researchers into the advances in the understanding of GPCR activation and constitutive activity. In addition, the book freeduan.com provides an overview on methods of investigating constitutive GPCR activity. The text is well illustrated by selected experimental data and schemes._The chaptes are all cross-referenced with each other and cover general mechnisms, methodological approaches and cover selected important GPCR sysstems, the consequences for drug action, including, side effects, and rational drug design for GPCR targets. A highly recommended reference for researchers in academia and industry.

authors addresses in detail current models and concepts, so as to introduce pharmaceutical chemists, physiologists and medical researchers to the advances in the understanding of GPCR activation and constitutive activity, and provides an overview of the methods of investigating GPCR activity. The text is backed by abundant case studies and methodological advice for analyzing GPCRs, covering selected pharmacologically relevant GPCR systems, the consequences for drug action, including unwanted side effects, and rational drug design for GPCR targets.
A highly practical reference for researchers in academia and industry.
http://www.daydownload.com/hosting.php?ref=cl3s8ZTaBwtS
http://www.daydownload.com/hosting.php?ref=61nFwsl3I1vU

[ Last edited by luai071 on 2007-6-9 at 15:18 ]
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
5Â¥2007-06-10 12:31:08
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 16 ¸ö»Ø´ð

wangye

½ûÑÔ (ÕýʽдÊÖ)

±¾ÌûÄÚÈݱ»ÆÁ±Î

2Â¥2007-06-09 18:12:11
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

cmuchchem

½ð³æ (ÕýʽдÊÖ)


¡ï Ò»ÐǼ¶,Ò»°ã

2¸öÎļþ¶¼ÒªÏÂÔØ¡£È»ºó¸Ä³ÉͬÃû£¬ÀýÈç°Ñ´óÎļþÃüÃûΪwww1.rar£¬Ð¡ÎļþΪwww2.rar£¬ÔÙ½âѹ¡£
3Â¥2007-06-09 18:47:40
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wangye

½ûÑÔ (ÕýʽдÊÖ)

±¾ÌûÄÚÈݱ»ÆÁ±Î

4Â¥2007-06-09 19:06:36
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸Öпƴó²ÄÁÏÓ뻯¹¤£¬353·Ö»¹Óе÷¼ÁѧУÂð +10 ·ñ¼«Ì©À´2026 2026-04-15 12/600 2026-04-17 17:54 by mapenggao
[¿¼ÑÐ] Ò»Ö¾Ô¸»¦9£¬326ÇóÉúÎïѧµ÷¼Á +11 Áõīī 2026-04-13 11/550 2026-04-17 15:35 by wanganpin
[¿¼ÑÐ] 322Çóµ÷¼Á +6 tekuzu 2026-04-17 6/300 2026-04-17 13:48 by Espannnnnol
[¿¼ÑÐ] 271Çóµ÷¼Á +37 2261744733 2026-04-11 39/1950 2026-04-17 10:11 by ºÚ¿Æ¼¼¿óÒµ
[¿¼ÑÐ] 291Çóµ÷¼Á +9 ¹ØÒä±±. 2026-04-14 9/450 2026-04-16 22:49 by cfdbai
[¿¼ÑÐ] Çóµ÷¼Á +8 СÄô°®Ñ§Ï° 2026-04-16 10/500 2026-04-16 22:06 by 1shin_ichi
[¿¼ÑÐ] »¯Ñ§070300 Çóµ÷¼Á +28 ¹þ¹þ¹þ^_^ 2026-04-12 28/1400 2026-04-16 21:36 by ´óÁ¦Ë®ÊÖÁ¦´óÎÞÇ
[¿¼ÑÐ] 294Çóµ÷¼Á +14 µ­È»654321 2026-04-15 14/700 2026-04-16 21:01 by lpl364211
[¿¼ÑÐ] ҩѧÇóµ÷¼Á +14 à¶¹þ¼ÓÓÍ 2026-04-14 16/800 2026-04-16 10:15 by beilsong20
[¿¼ÑÐ] ҩѧ305Çóµ÷¼Á +7 Â꿨°Í¿¨boom 2026-04-11 7/350 2026-04-15 13:21 by Î÷±±Íû¡ª·çɳ
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +21 »ý¼«ÏòÉÏ£» 2026-04-10 23/1150 2026-04-15 12:50 by Î÷±±Íû¡ª·çɳ
[¿¼ÑÐ] ²ÄÁϹ¤³Ì281»¹Óе÷¼Á»ú»áÂð +43 xaw. 2026-04-11 44/2200 2026-04-15 12:46 by Î÷±±Íû¡ª·çɳ
[¿¼ÑÐ] Çóµ÷¼Á +12 ºÎÆøÕý 2026-04-13 13/650 2026-04-14 14:47 by zs92450
[¿¼ÑÐ] 085408¹âµçÐÅÏ¢¹¤³Ìר˶355Ò»Ö¾Ô¸³¤´º¹â»úËùµ÷¼Á +6 Íõymaa 2026-04-13 13/650 2026-04-14 11:33 by Íõymaa
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤329·ÖÇóµ÷¼Á +24 Ò¶zilin 2026-04-13 25/1250 2026-04-14 09:20 by ÊÔ¹ÜÆÆÁÑ
[¿¼ÑÐ] 293Çóµ÷¼Á +16 ÎÒ°®¸ßÊý¸ßÊý°®Î 2026-04-12 18/900 2026-04-13 21:47 by ѧԱJpLReM
[¿¼ÑÐ] 297¹¤¿Æ£¬Çóµ÷¼Á? +13 ºÓÄÏũҵ´óѧ-ÄÜ 2026-04-12 13/650 2026-04-13 14:12 by dingyanbo1
[¿¼ÑÐ] 352 Çóµ÷¼Á +6 yzion 2026-04-11 8/400 2026-04-11 16:24 by Ã÷Ô´ËʱÓÐ
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸´óÁ¬Àí¹¤´óѧ354·Ö +5 ÓêÉùÓàÉú 2026-04-11 6/300 2026-04-11 16:12 by ÓêÉùÓàÉú
[¿¼ÑÐ] ũѧ0904 312Çóµ÷¼Á +6 Say Never 2026-04-10 6/300 2026-04-11 10:33 by wwj2530616
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û